Targeted cytotoxic therapy kills persisting HIV infected cells during ART - Wikidata - wikimedia - TriplyDB

Targeted cytotoxic therapy kills persisting HIV infected cells during ART

Targeted cytotoxic therapy kills persisting HIV infected cells during ART

http://www.wikidata.org/entity/Q28538598

about

Animal Models for HIV Cure Research Studies of retroviral infection in humanized mice Towards an HIV cure based on targeted killing of infected cells: different approaches against acute versus chronic infection Structural basis for the inhibition of HIV-1 Nef by a high-affinity binding single-domain antibody Using animal models to overcome temporal, spatial and combinatorial challenges in HIV persistence research Are T cells the only HIV-1 reservoir?Bioinformatics and HIV latency.Latency reversal and viral clearance to cure HIV-1.When noise makes music: HIV reactivation with transcriptional noise enhancers.The potential of radioimmunotherapy as a new hope for HIV patients.HIV-1 DNA predicts disease progression and post-treatment virological control.Exploring the potential of monoclonal antibody therapeutics for HIV-1 eradication.Translational challenges in targeting latent HIV infection and the CNS reservoir problem.Dynamics of HIV latency and reactivation in a primary CD4+ T cell model.Eradicating HIV-1 infection: seeking to clear a persistent pathogen.Humanized mouse models for HIV-1 infection of the CNS.Vectored antibody gene delivery for the prevention or treatment of HIV infection.HIV pre-exposure prophylaxis: mucosal tissue drug distribution of RT inhibitor Tenofovir and entry inhibitor Maraviroc in a humanized mouse model.Specific Elimination of Latently HIV-1 Infected Cells Using HIV-1 Protease-Sensitive Toxin Nanocapsules.A Murine Viral Outgrowth Assay to Detect Residual HIV Type 1 in Patients With Undetectable Viral Loads Dual-Affinity Re-Targeting proteins direct T cell-mediated cytolysis of latently HIV-infected cells.Human Immunodeficiency Virus Type 1 Monoclonal Antibodies Suppress Acute Simian-Human Immunodeficiency Virus Viremia and Limit Seeding of Cell-Associated Viral Reservoirs.In vivo platforms for analysis of HIV persistence and eradication.Towards HIV-1 remission: potential roles for broadly neutralizing antibodies.Recent developments in the effort to cure HIV infection: going beyond N = 1.Improvements and Limitations of Humanized Mouse Models for HIV Research: NIH/NIAID "Meet the Experts" 2015 Workshop Summary.ART influences HIV persistence in the female reproductive tract and cervicovaginal secretions.Macrophages sustain HIV replication in vivo independently of T cells CD19xCD3 DART protein mediates human B-cell depletion in vivo in humanized BLT mice HIV cure research: a formidable challenge Combination of Antiretroviral Drugs and Radioimmunotherapy Specifically Kills Infected Cells from HIV-Infected Individuals.Design and In Vivo Characterization of Immunoconjugates Targeting HIV gp160.Identification of Human Anti-HIV gp160 Monoclonal Antibodies That Make Effective Immunotoxins.Predicting HIV Pre-exposure Prophylaxis Efficacy for Women using a Preclinical Pharmacokinetic-Pharmacodynamic In Vivo Model.International AIDS Society global scientific strategy: towards an HIV cure 2016.Targeting HIV latency: resting memory T cells, hematopoietic progenitor cells and future directions.Finding a cure for human immunodeficiency virus-1 infection.The future of antiviral immunotoxins.Engineering broadly neutralizing antibodies for HIV prevention and therapy.Humanized mice for HIV and AIDS research.

P2860

Q26767476-31441D69-9885-40B9-B2B6-2D755F773156 Q26849806-E42C8AC3-8311-4149-95A1-714E4F49B08E Q27005830-2F8A951C-1BAE-4927-88AD-2D984B7FE941 Q27682132-FF9CA39A-9837-47A4-BEFA-140BD858CBB5 Q28077662-C9C5AEF1-D956-40A5-86A0-B6137AF13875 Q28078850-6B3EF6E0-9296-413F-BBC5-58630016F0FF Q28081427-450C174A-D50B-4175-98DA-89096A8CEC59 Q30248766-C77DD25D-5F53-4700-B0C2-4EF0FEF97929 Q30367371-A263F4E4-1189-415B-891E-4BB465A391A6 Q33863509-E266A8DE-7603-4150-A252-8AE7F037817A Q34350410-882E2FF5-475E-4098-86F8-A959889727E7 Q34869927-34BF4519-BC3F-4836-82FC-A11C062817D0 Q35009744-C7FE298E-917B-4B39-AFB8-CE37B80B47FE Q35176166-B3321B16-7E1C-4574-AF86-4769EA58D322 Q35252186-C664AEB2-83DD-4AA1-B765-00483D7C1F85 Q35567215-D451D059-9766-4FAE-BB81-AE80C6AC1151 Q35664155-2EE0CBCF-938B-424F-B40A-6FC9A8739D7E Q35794988-266D15D0-1FEE-41B5-9268-ED92325DA779 Q35980789-9FBFB5AF-7544-47A9-9005-F3D726EB31D6 Q36149000-9783E1BE-65C0-49FA-882E-3CA8F2ABAE31 Q36266486-1F5675A1-5F21-4EE9-8D02-54A70C471310 Q36481483-CEE1BA7E-3D12-4868-BBBC-32BDDDC46C8F Q36515119-60843BC9-49D6-49A5-9AC5-369ED73B2543 Q36515149-58F06B9C-9400-421C-AB06-FD62C6A52296 Q36515170-B3C10E07-0AFF-4032-986B-1B363225CB6D Q36601983-3DB66E02-E457-43A0-ADFB-56BE4FB456D4 Q36618563-54EAFF38-99CD-4701-9838-EF357E9FA6FA Q36737917-A20FEC5A-6CD5-4DDA-8386-69621463B7D3 Q36777155-7A3245D4-DBEA-475C-86ED-8D26219AC22E Q37098202-3A325663-7922-440B-8A81-04DF99E3B51B Q37281138-282C88C9-1C18-4FE4-9AEF-083FCE0BE05A Q37593171-677FD6F4-946B-4920-AE3B-B9B15DF30B40 Q37593177-B3A11202-801D-4771-AF01-6FD32ABCF406 Q37618260-37CCC0DA-A2B3-4D88-A3B4-1F28DBDEE842 Q37661770-393FE24D-9F1D-40B2-8493-139A4D0778CE Q38246141-02EC6574-A52F-4389-9A14-A0BEEAD9E9BB Q38256237-D8DE5668-D901-4FEF-AFD1-2150DD3CAD63 Q38686601-0FE64B57-4D0C-4054-B1DD-6EA2C41F202E Q38717198-ED5A2D73-40ED-4F07-B295-4B37877C39A1 Q38838864-46A7A451-6FBF-4D9B-97CD-0C75D407CF55

P2860

Targeted cytotoxic therapy kills persisting HIV infected cells during ART

http://www.wikidata.org/entity/Q28538598

description

2014 nî lūn-bûn

@nan

2014 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Targeted cytotoxic therapy kills persisting HIV infected cells during ART

@ast

Targeted cytotoxic therapy kills persisting HIV infected cells during ART

@en

Targeted cytotoxic therapy kills persisting HIV infected cells during ART

@nl

type

label

Targeted cytotoxic therapy kills persisting HIV infected cells during ART

@ast

Targeted cytotoxic therapy kills persisting HIV infected cells during ART

@en

Targeted cytotoxic therapy kills persisting HIV infected cells during ART

@nl

prefLabel

Targeted cytotoxic therapy kills persisting HIV infected cells during ART

@ast

Targeted cytotoxic therapy kills persisting HIV infected cells during ART

@en

Targeted cytotoxic therapy kills persisting HIV infected cells during ART

@nl

P1433

Q28538598-5AF5A2FA-2E32-43FF-B0F4-DBA3955FC047

P1476

Q28538598-B27EE676-E8F1-4EC5-BC9F-BA1512226ECD

P2093

Q28538598-02F4C4E8-0290-4686-8926-E0B33B50C01B

Q28538598-06AB4CBC-495F-4795-9CAC-7D364B074A7A

Q28538598-1ACBBF86-2FE3-4BE2-84A0-31C73270DDB8

Q28538598-4AA479CB-26F0-4F62-9656-3B1D8AA5A33B

Q28538598-5DC99CF3-58D2-45C6-A152-5A061C5A5255

Q28538598-6091466C-55CD-404D-BBA6-F762C246BA2F

Q28538598-65F6EC43-0457-46DA-82DE-12E51E650284

Q28538598-88CD50D6-9432-495D-8FA0-260C1EF15D18

Q28538598-93B8AAB8-482C-4919-88DC-F55B54073AD3

Q28538598-958DEFCC-DCC0-49EC-87F6-F9291FBE2D3B

P2860

Q28538598-003CE5DC-12BF-4DAD-B32C-173DA2977C4C

Q28538598-05F426A8-CC1C-444F-908B-8B6F27CC6048

Q28538598-072323E6-F0E7-439E-ACA8-98DC043C25F2

Q28538598-09B0439B-18C8-48E6-A2E9-94830C41199D

Q28538598-09F84A32-27A1-4AB2-8354-84EE8C616F55

Q28538598-0F7ADAD1-FFF0-4A5C-AAE9-8DE247F06661

Q28538598-1237F4D0-FF81-4FF4-9F37-B64C7E527F95

Q28538598-13B0D4D7-7DFC-498C-A0B7-9BE34CA1D22D

Q28538598-13E71C2A-76A2-4EB8-8631-138B7090ED1F

Q28538598-160E2026-73E1-45F0-BB9E-C29C193FECA2

P304

Q28538598-66805FFD-5269-4CE6-B9A9-37DA287331E8

P31

Q28538598-61C0E400-F50B-4405-BE8C-4C8518BF1DFE

P3181

Q28538598-891C5875-5986-4941-82F6-BBDAA5760725

P356

Q28538598-2D199559-9AA7-42A8-A2C8-94747BFE4115

P407

Q28538598-78B98429-3A18-4E44-97D0-2646975E8B40

P433

Q28538598-3E32BF60-1BF0-4A18-8908-E008A6FD4E40

P478

Q28538598-E16F46F4-3060-44A9-B05F-713D99A8C23F

P50

Q28538598-E5557AF3-6608-4CED-B334-AF486A369152

Q28538598-EEA728D2-681E-491F-899B-4BF7F24E267B

P577

Q28538598-B17723AC-B067-4292-86E3-208AE6F02BBD

P5875

Q28538598-3393268A-99C4-42A3-9D35-1EB4ED4F07C0

P698

Q28538598-48F63D21-C487-4BD2-9691-D781C7CD9783

P921

Q28538598-C8C18E0E-3029-4C56-9B7E-9F2D3BE1BB6E

P932

Q28538598-75594820-5BEB-4EEF-BFFB-53956835CE96

P3181

P356

JOURNAL.PPAT.1003872

P1433

P1476

Targeted cytotoxic therapy kills persisting HIV infected cells during ART

@en

P2093

Angela D Kashuba

http://www.w3.org/2001/XMLSchema#string

Ashley T Haase

http://www.w3.org/2001/XMLSchema#string

Craig Sykes

http://www.w3.org/2001/XMLSchema#string

Edward A Berger

http://www.w3.org/2001/XMLSchema#string

Ira Pastan

http://www.w3.org/2001/XMLSchema#string

J Victor Garcia

http://www.w3.org/2001/XMLSchema#string

Julie M Long

http://www.w3.org/2001/XMLSchema#string

Katherine Perkey

http://www.w3.org/2001/XMLSchema#string

Kuo Yang

http://www.w3.org/2001/XMLSchema#string

Michael G Hudgens

http://www.w3.org/2001/XMLSchema#string

P2860

Human breast milk and antiretrovirals dramatically reduce oral HIV-1 transmission in BLT humanized mice

Antiretroviral pre-exposure prophylaxis prevents vaginal transmission of HIV-1 in humanized BLT mice

In vitro evolution of a neutralizing human antibody to human immunodeficiency virus type 1 to enhance affinity and broaden strain cross-reactivity

Selective inhibition of human immunodeficiency viruses by racemates and enantiomers of cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine

Anti-human immunodeficiency virus activity and cellular metabolism of a potential prodrug of the acyclic nucleoside phosphonate 9-R-(2-phosphonomethoxypropyl)adenine (PMPA), Bis(isopropyloxymethylcarbonyl)PMPA

Specific killing of HIV-infected lymphocytes by a recombinant immunotoxin directed against the HIV-1 envelope glycoprotein

Immunotoxin complementation of HAART to deplete persisting HIV-infected cell reservoirs

Viral sanctuaries during highly active antiretroviral therapy in a nonhuman primate model for AIDS

Human immunodeficiency virus-infected T cells and monocytes are killed by monoclonal human anti-gp41 antibodies coupled to ricin A chain.

Biphasic decay of latently infected CD4+ T cells in acute human immunodeficiency virus type 1 infection.

P304

e1003872

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1455224

http://www.w3.org/2001/XMLSchema#string

P356

10.1371/JOURNAL.PPAT.1003872

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

10

http://www.w3.org/2001/XMLSchema#string

P50

David M. Margolis

P577

2014-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

259701282

http://www.w3.org/2001/XMLSchema#string

P698

24415939

http://www.w3.org/2001/XMLSchema#string

P921

P932

3887103

http://www.w3.org/2001/XMLSchema#string